Table 5. Proportion of fatty acids in pelvic limb at 39 weeks (n = 10 for each condition).

		Ad		Rt		P-value
	Ctrl	Supp	Ctrl	Supp	Diet	Supp	Diet*Supp
C18:2	27.76 ± 0.61	24.20 ± 0.67	29.43 ± 1.14	28.54 ± 0.88	0.002	0.02	0.15
C18:3	2.03 ± 0.15	1.50 ± 0.11	2.02 ± 0.09	1.76 ±0.01	0.34	0.002	0.29
C20:4 n-6	1.73 ± 0.26	1.51 ± 0.11	1.90 ± 0.34	1.71 ± 0.01	0.52	0.49	0.94
C20:5 n-3	0.12 ± 0.03	0.24 ± 0.04	0.07 ± 0.02	0.14 ± 0.002	0.02	0.005	0.39
C22:4 n-6	0.18 ± 0.04	0.08 ± 0.02	0.14 ± 0.03	0.10 ± 0.002	0.72	0.01	0.30
C22:5 n-3	0.15 ± 0.02	0.23 ± 0.01	0.22 ± 0.03	0.26 ± 0.004	0.21	0.10	0.67
C22:6 n-3	0.41 ± 0.08	0.59 ± 0.04	0.45 ± 0.07	0.72 ± 0.03	0.41	0.03	0.67
n-6	29.68 ± 0.83	25.80 ± 0.70	31.48 ± 1.24	30.36 ± 0.87	0.002	0.01	0.17
n-3	2.73 ± 0.22	2.58 ± 0.16	2.78 ± 0.13	2.89 ± 0.04	0.33	0.91	0.47
n-6/n-3	11.39 ± 0.85	10.31 ±0.68	11.37 ± 0.34	10.76 ± 0.15	0.73	0.19	0.71

Results are presented as lsmeans ± SEM. P values of the effects of diet, supplementation and the interaction between diet and supplementation were considered as significant if P ≤ 0.05. Ad: ad libitum, Rt: restricted, Supp: supplemented, Ctrl: control unsupplemented